Novartis AG announced disappointing sales for a key psoriasis drug and the looming retirement of its respected finance chief, which overshadowed a modest outlook raise.

Patients with psoriasis have a higher risk for synovitis on imaging than healthy individuals, according to a systematic ...

"Apremilast remains an attractive therapeutic option, even for ICI-PsA, given that it is not immunosuppressive and therefore ...

Normally, skin cells take about a month to form and rise to the surface. In people with psoriasis, this process happens in ...

A large cohort study of patients with psoriasis using wearable devices finds more exercise is associated with a lower risk ...

New research identifies diabetes as an independent predictor of major adverse cardiovascular events in patients with both ...

How to tell if you have psoriasis or ringworm as these two skin conditions look similar but need completely different ...

A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals ...

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

Some medicines used for heart problems, like beta-blockers, ACE inhibitors, and calcium channel blockers, have been known to ...

AD and psoriasis were once thought to be opposites in terms of immune response, with AD linked to a Th2-dominant pathway and ...